One infusion could beat daily pills for Post-Birth anemia
NCT ID NCT05590260
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study tests whether a single intravenous (IV) dose of iron works better than daily oral iron pills to treat moderate anemia in new mothers. About 4,800 women who have moderate anemia 6 to 48 hours after delivery will receive either a one-time IV iron infusion plus folic acid, or standard oral iron tablets plus folic acid for six months. The main goal is to see if more women in the IV group reach a healthy hemoglobin level by six weeks after birth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ferric carboxymaltose (IV iron) and folic acid
- What this could lead to
- If it works, this could offer a faster, more effective way to treat postpartum anemia, helping new mothers regain energy and reduce depression risk.
- What could go wrong
- This is a single trial; results may not apply to all women. IV iron carries rare risks like allergic reactions, and the benefit over oral iron may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM ANEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ICDDRB
Dhaka, 1212, Bangladesh
-
INCAP
Guatemala City, Guatemala
-
KLE Society's Jawaharlal Nehru Medical College
Belagavi, Karnataka, 590 010, India
-
Kinshasa School of Public Health
Kinshasa, Democratic Republic of the Congo
-
Lata Medical Research Foundation
Nagpur, India, India
-
Moi University School of Medicine
Eldoret, 30100, Kenya
-
The Aga Khan University
Karachi, Pakistan, 74800, Pakistan
-
University Teaching Hospital
Lusaka, Zambia
More trials for these conditions
Other studies related to the condition(s) this trial covers.